Metabolites,
Journal Year:
2024,
Volume and Issue:
14(12), P. 692 - 692
Published: Dec. 9, 2024
Insulin
resistance
(IR)
is
central
to
the
progression
of
non-alcoholic
fatty
liver
disease
(MAFLD).
While
aerobic
exercise
reduces
hepatic
fat
and
enhances
insulin
sensitivity,
specific
mechanisms-particularly
those
involving
exosomal
pathways-are
not
fully
elucidated.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(7), P. 3694 - 3694
Published: March 26, 2024
Metabolic-associated
fatty
liver
disease
(MAFLD)
includes
several
metabolic
dysfunctions
caused
by
dysregulation
in
the
brain–gut–liver
axis
and,
consequently,
increases
cardiovascular
risks
and
dysfunction.
In
MAFLD,
type
2
diabetes
mellitus,
obesity,
syndrome
are
frequently
present;
these
conditions
related
to
lipogenesis
systemic
inflammation.
This
study
aimed
review
connection
between
MAFLD.
The
inflammatory
process,
cellular
alterations
hepatocytes
stellate
cells,
hypercaloric
diet,
sedentarism
aggravate
prognosis
of
patients
with
Thus,
understand
modulation
physiopathology
it
is
necessary
include
organokines
involved
this
process
(adipokines,
myokines,
osteokines,
hepatokines)
their
clinical
relevance
project
future
perspectives
condition
bring
light
new
possibilities
therapeutic
approaches.
Adipokines
responsible
for
activation
distinct
signaling
different
tissues,
such
as
insulin
pro-inflammatory
cytokines,
which
important
balancing
substances
avoid
MAFLD
its
progression.
Myokines
improve
quantity
quality
adipose
contributing
avoiding
development
Finally,
hepatokines
decisive
improving
or
not
progression
through
regulation
anti-inflammatory
organokines.
Pakistan Journal of Medical Sciences,
Journal Year:
2025,
Volume and Issue:
41(2), P. 512 - 518
Published: Jan. 23, 2025
Objective:
Sequential
therapy
in
traditional
Chinese
medicine
(TCM)
refers
to
a
combination
of
internal
and
external
treatment
methods
certain
order
based
on
syndrome
differentiation
therapy.
The
aim
this
study
was
evaluate
the
efficacy
TCM
sequential
that
is
given
basis
conventional
management
patients
with
non-alcoholic
fatty
liver
disease
(NAFLD).
Methods:
Medical
records
one
hundred
NAFLD
who
received
at
Zhejiang
Provincial
Tongde
Hospital
between
February
2023
April
2024
were
retrospectively
analyzed.
Of
them,
48
routine
intervention
(Control
group),
52
additionally
treated
by
(TCM
group).
levels
blood
lipid
indicators,
function
efficacy,
quality
life
(QOL)
scores
compared
two
groups
before
after
intervention.
Results:
After
intervention,
indicators
both
significantly
improved
preintervention
considerably
better
Control
group
(P<0.05).
overall
higher
(94.23%)
(79.17%)
QOL
increased
than
Conclusions:
For
patients,
adopting
addition
strategies
can
effectively
regulate
patients’
levels,
restore
function,
improve
effectiveness,
life.
doi:
https://doi.org/10.12669/pjms.41.2.11352
How
cite
this:
Zhang
L,
Qian
Y,
Wu
H,
Xu
H.
disease.
Pak
J
Med
Sci.
2025;41(2):512-518.
This
an
Open
Access
article
distributed
under
terms
Creative
Commons
Attribution
License
(http://creativecommons.org/licenses/by/3.0),
which
permits
unrestricted
use,
distribution,
reproduction
any
medium,
provided
original
work
properly
cited.
Journal of Pharmacy and Pharmacology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 9, 2024
Abstract
Objectives
In
China,
there
is
a
long
history
and
rich
clinical
experience
in
treating
nonalcoholic
steatohepatitis
(NASH)
with
traditional
Chinese
herbal
medicines,
including
Chai
Hu
Shu
Gan
San.
This
study
aims
to
investigate
the
potential
regulatory
effects
of
Chaihu
Shugan
San
(CSS)
on
liver
lipid
metabolism
inflammatory
damage
mice
experimental
induced
by
choline-deficient
high-fat
diet
(CDHFD).
Utilizing
network
pharmacology,
we
systematically
explore
mechanisms
action
therapeutic
CSS
against
NASH.
Methods
Potential
targets
for
NASH
were
identified
using
online
databases.
Functional
enrichment
protein–protein
interaction
analyses
conducted
identify
hub-targeted
genes
elucidate
underlying
molecular
mechanisms.
The
affinities
active
compounds
evaluated
docking.
Finally,
validated
through
real-time
polymerase
chain
reaction,
western
blotting,
immunofluorescence
mice,
both
without
treatment.
Key
findings
reduces
serum
ALT
AST
levels
mice(P
<
0.05)
ameliorates
ballooning
degeneration
livers
thereby
lowering
NAS
score(P
0.05).
Including
naringenin,
high-performance
liquid
chromatography/mass
spectrometrys
12
chromatographic
peaks.
Based
pharmacology
analysis,
contains
total
103
877
target
genes.
Transferase
activity
represents
mechanism
intervention
transcriptional
protein
expression
SIRT1
gene
are
significantly
increased
(P
Conclusions
Naringenin
probable
compound
hub
which
involved